Capella Scientia Development Study
ConditionCataract
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAlcon Research
About this trial
This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.
Eligibility criteria
Qualifiers
Able to understand and sign an IRB/IEC approved consent form;
Willing and able to attend study visit(s) as required by the protocol;
Consenting age at the jurisdiction of study site;
Other group-specific, protocol required inclusion criteria may apply.
Disqualifiers
Women of child-bearing potential;
Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus);
Unclear optical media preventing data capture from all devices in the study;
Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment;
Trial design
Treatments tested in this trial
- Unity DX and SMARTCataract DX (SCDX) Biometer
- IOLMaster 700 Biometer
- Argos with Alcon Image Guidance Biometer
Treatment groups
400 Participants
are divided into 4 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov